Nuo Therapeutics, (id:11263 AURX)
1.09 USD
Opening hours: 09:30 - 16:00 (Eastern Standard Time: 11/24/2024 9:26:23 PM)
Exchange closed, opens in 12 hours 3 minutes
36.25 USD (36.25%)
81.67 USD (81.67%)
43.32 USD (43.32%)
127.08 USD (127.08%)
1,111.11 USD (1,111.11%)
1,262.50 USD (1,262.50%)
About Nuo Therapeutics,
Market Capitalization 50.79M
Nuo Therapeutics, Inc., a regenerative therapies company, develops, commercializes, and markets cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing in the United States. The company offers the Aurix System, which separates autologous blood to produce a platelet-based therapy for the chronic wound care market. It serves hospital outpatient wound care clinics and other private practice physicians treating chronic wounds. The company was formerly known as Cytomedix, Inc. and changed its name to Nuo Therapeutics, Inc. in November 2014. Nuo Therapeutics, Inc. was incorporated in 1998 and is based in Houston, Texas.
| Headquarters (address) |
8285 El Rio Houston 77054 TX United States |
| Phone | 346 396 4770 |
| Website | https://www.nuot.com |
| Employees | 9 |
| Sector | Healthcare |
| Industry | Biotechnology |
| Ticker | AURX |
| Exchange | OTC Markets U.S. |
| Currency | USD |
| 52 week range | 0.252 - 1.27 |
| Market Capitalization | 50.79M |
| P/E trailing | -13.62 |
| Price/Sale | 83.47 |
| Price/Book | 47.39 |
| Beta | -740.14 |
| EPS | -0.060 |
| EPS United States (ID:6, base:3402) | 24.23 |